< Back to latest news & events

UPC

SPCs and Unitary Patents

December 2015

Currently, Supplementary Protection Certificates (SPCs) can be obtained on the basis of granted European patents. But there is a question mark over the possibility of obtaining unitary SPCs on the basis of granted European Unitary Patents.

There is no legislation that covers the possibility of a “unitary” SPC. Even though an EU wide Marketing Authorisation is possible, there is no centralised system that would allow for a “unitary” SPC. Although individual national SPC applications could be made on the basis of the granted UP, industry are still seeking certainty of how this would work in practice.

ECPA, efpia & IFAH have made a joint industry proposal for a unitary SPC to the European Commission, recognising “the importance and value of SPCs” and to show they “support the concept of unitary SPCs being granted on the basis of European Patents with unitary effect”. The proposal is that unitary SPCs on the basis of European unitary patents would be granted by a virtual body composed of SPC experts from national patent offices.

Given the rate at which progress is being made on other areas of legislation and infrastructure surrounding the unitary patent and unified patent court, the situation regarding SPCs will need to be addressed as soon as possible.

Latest updates

Event - 30th - 31st October 2025

RAPS European Digital Technologies and Software conference

HGF is proud to be attending the RAPS European Digital Technologies and Software conference in The Netherlands on 30th-31st October. HGF Partner and Patent Attorney Janine Swarbrick and Patent Director …

Event details

Protect It Before You Promote It: IP Advice for MedTech Innovators

Developed a new medical product? Check. Got tickets to an exciting MedTech conference to show off your new product? Check. Intellectual property? Pardon? In the excitement of bringing a new …

Read article

Agritech Thymes: The Bite of Implied Consent: Lessons from the Pink Lady Case

Can the supply of a plant variety without clear and defined restrictions on its use be an implicit consent to commercialise it? This case centres on the evidence required to …

Read article

IAM Global Leaders 2026

HGF is proud to announce that we have 3 partners listed as an IAM Global Leader 2026. To qualify for inclusion in the IAM Global Leaders, individuals must be ranked …

Read article

The Bite of Implied Consent: Lessons from the Pink Lady Case

A recent European Union court decision considers the issue of implied consent to commercialise a plant variety, and whether the evidence meets the threshold of “serious doubts” of the validity …

Read article
Event - 5th November 2025

HGF are Gold Sponsors of IAM Live: Navigating the UPC 2025

We’re excited to share that HGF is a Gold Sponsor of IAM Live: Navigating the UPC 2025, taking place on the 5th November at the Marriott Opera Ambassador Hotel in …

Event details

HGF ranked band 1 in Chambers and Partners UK 2026

The Chambers and Partners UK 2026 Guide is now live and HGF has one again been highly ranked as a firm, with several recognised individuals across multiple regions. HGF is …

Read article

How France's investment in digital health, AI, and bioinformatics is transforming the intellectual property (IP) landscape

In recent years, France has become a key player in digital health innovation, driven by strategic government investments under the France 2030 initiative and the French Tech 2030 program. These …

Read article